CYP2D6 testing to guide risperidone and aripiprazole therapy
- PMID: 31000416
- DOI: 10.1016/S2215-0366(19)30138-5
CYP2D6 testing to guide risperidone and aripiprazole therapy
Comment on
-
Effect of CYP2D6 genotype on exposure and efficacy of risperidone and aripiprazole: a retrospective, cohort study.Lancet Psychiatry. 2019 May;6(5):418-426. doi: 10.1016/S2215-0366(19)30088-4. Epub 2019 Apr 15. Lancet Psychiatry. 2019. PMID: 31000417
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
